Acumen Pharmaceuticals Inc (ABOS)
2.95
-0.03
(-1.01%)
USD |
NASDAQ |
May 31, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Accounts Payable (Quarterly): 3.079M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.079M |
December 31, 2023 | 1.379M |
September 30, 2023 | 1.362M |
June 30, 2023 | 2.026M |
March 31, 2023 | 0.762M |
December 31, 2022 | 1.64M |
September 30, 2022 | 2.084M |
Date | Value |
---|---|
June 30, 2022 | 1.71M |
March 31, 2022 | 1.219M |
December 31, 2021 | 1.088M |
September 30, 2021 | 0.382M |
June 30, 2021 | 2.907M |
March 31, 2021 | 0.918M |
December 31, 2020 | 0.531M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.382M
Minimum
Sep 2021
3.079M
Maximum
Mar 2024
1.506M
Average
1.370M
Median
Accounts Payable (Quarterly) Benchmarks
Accuray Inc | 44.43M |
Kezar Life Sciences Inc | 5.059M |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 3.443M |
iBio Inc | 1.228M |